Nivestym (filgrastim-aafi) Injection, 300 mcg/mL, Single-Dose Vial, 10/Package

Nivestym (filgrastim-aafi) is a leukocyte growth factor indicated to decrease the incidence of infection in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs. This formulation is supplied as a 300 mcg/mL solution in single-dose vials, packaged 10 vials per package.